National Academy of Sciences | 150 Year Anniversary

Questions? Call 800-624-6242

| Items in cart [0]

The National Academies Press

PAPERBACK
price:$42.00
add to cart

Rights & Permissions

topleft topright

Biological Science and Biotechnology in Russia: Controlling Diseases and Enhancing Security (2005)
Development, Security, and Cooperation (DSC)

Citation Manager

. "Appendix K Scientific and Methodological Research Results Highlighted by the Russian Ministry of Health and Social Development." Biological Science and Biotechnology in Russia: Controlling Diseases and Enhancing Security. Washington, DC: The National Academies Press, 2005.

Please select a format:

BibTeX EndNote RefMan


Page
121
bottomleft bottomright

The following HTML text is provided to enhance online readability. Many aspects of typography translate only awkwardly to HTML. Please use the page image as the authoritative form to ensure accuracy.


Biological Science and Biotechnology in Russia: Controlling Diseases and Enhancing Security

Methods have been developed for assessing the intensity of local and systemic immunity to Corynebacteria diphtheriae. Based on diphtheria infection models, a set of immunity status analysis methods has been developed for the first time, making it possible to evaluate the intensity of antibacterial and anti-toxic immunity (I. N. Blokhina Scientific-Research Institute of Epidemiology and Microbiology, Nizhny Novgorod).

Researchers have discovered certain features of the genetic characteristics of HIV-1 strains circulating among risk groups. It was shown that one strain of HIV-1 caused more than 80 percent of all cases of HIV infection in Russia. Three recombinant varieties of HIV-1 were found in Russia—A/E, D/G, and A/G—which attests to the substantial contribution of such viruses to the epidemiological process of HIV infection in our country. Based on these research results, nucleotide sequences obtained from 250 new varieties of HIV-1 have been deposited in the International Gene Bank (GenBank). Another result of this work was the application in specific epidemiological research studies of molecular-epidemiological methods based on the genetic characterization of HIV-1 varieties (Russian Academy of Medical Sciences D. I. Ivanovsky Scientific Research Institute of Virology, Russian Academy of Medical Sciences O. G. Andzhaparidze Scientific-Research Institute of Viral Preparations, and various applied research institutes focusing on problems of diagnosing and preventing HIV infections and AIDS).

The effectiveness of using the phytopreparation Erakond to provide pregnant women with non-specific protection against herpetic and respiratory viruses has been demonstrated (Scientific-Research Institute of Viral Infections, Yekaterinburg).

Various types of test systems based on hybrids producing type 1 and 2 antibodies have been designed to detect antigens to the herpes simplex virus. Genetic methods have been developed for serogrouping, typing, and clonal analysis of meningococci (Russian Academy of Medical Sciences O. G. Andzhaparidze Scientific-Research Institute of Viral Preparations, Moscow).

In conjunction with efforts to improve the epidemiological monitoring system, the following accomplishments have been made:

  • A system for unified epidemiological monitoring of measles and rubella has been developed, and further research has been done to document its scientific foundations (G. N. Gabrichevsky Scientific-Research Institute of Epidemiology and Microbiology, Moscow).

  • Two types of recombinant protein-based immunoenzyme systems have been designed to determine specific IgG and IgM antibodies to the rubella virus. A seroepidemiological study has been conducted regarding postinfection and postvaccination immunity to the rubella virus among various groups in the population (Russian Academy of Medical Sciences O. G. Andzhaparidze Scientific-Research Institute of Viral Preparations, Moscow).

Page
121
Front Matter (R1-R10)
Summary (1-9)
Introduction (10-20)
1 The Vision for Russia’s Future (21-26)
2 Pillar One: Improving Surveillance and Response (27-35)
3 Pillar Two: Meeting Pathogen Research Challenges (36-46)
4 Pillar Three: The Promise of Biotechnology (47-58)
5 Pillar Four: The Human Resource Base (59-64)
6 Reshaping U.S.-Russian Cooperation in the Biological Sciences and Biotechnology (65-75)
Epilogue (76-78)
Appendix A Committee Biographies (79-85)
Appendix B Organizations Consulted During the Study (86-88)
Appendix C Decision of the Board of the Ministry of Health of the Russian Federation: Tasks for the Periods 2001-2005 and 2006-2010 from Protocol #6 (89-92)
Appendix D Main Goals and Objectives in Combating Infectious Diseases in the Russian Federation (93-95)
Appendix E Regulations on the Federal Service for the Supervision in the Sphere of Health and Social Development (96-103)
Appendix F Recent Reports by the National Academies on Global Health Concerns (104-105)
Appendix E Regulations Regarding the Federal Service for the Supervision in the Sphere of Health and Social Development (106-107)
Appendix H Highest Priority Measures for Creating a System to Counter Biological Terrorism (108-112)
Appendix I National Immunization Calendar of the Russian Federation (113-114)
Appendix J Selected Russian Research and Related Institutions with Activities Relevant to Infectious Diseases, Diagnostics, Treatment, Prevention, and Control (115-119)
Appendix K Scientific and Methodological Research Results Highlighted by the Russian Ministry of Health and Social Development (120-124)
Appendix L List of Research Projects Proposed in Open Competitions Organized in 2003 (125-126)
Appendix M Test Systems and Other Products Being Developed in Russian Laboratories (127-130)
Appendix N RosAgroBioProm Organizational Structure (131-131)
Appendix O Activities of Russian Research Institutes in Developing Vaccines for Human Use (132-132)
Appendix P Regulation of the Russian Government on Licensing Activities Connected with the Use of Infectious Disease Antidotes, No. 731 (133-136)
Appendix Q Bioengagement Programs Financed by the United States Government (137-142)
Appendix R International Programs and Projects of Special Significance to the Ministry of Health and Social Development (143-144)
Selected Bibliography (145-146)